EXCLUSIVES
Chandigarh Calling!
Pharma experts and leaders unite to unravel opportunities for India Pharma Inc…
Interviews
These 40 bets would deliver $30-$50 bn additional growth to healthcare sector by 2029
Kapil Khandelwal, Managing Partner of El-Toro Finserve LLP, the Investment Manager of several funds investing in Indian Healthcare…
Targeted funding strategies and policy interventions are key to make rare disease treatments…
Coinciding with the recent observance of Rare Diseases Day on February 29, 2024, Anil Matai, Director General of OPPI, accentuated…
I envision India becoming a magnet for the global biotech manufacturing market
In a freewheeling chat with Viveka Roychowdhury, Dr Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance…
Specials
Fortifying defence against zoonoses
Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases